Statistics for AXL Targeting Restores PD-1 Blockade Sensitivity of STK11/LKB1 Mutant NSCLC Through Expansion of TCF1+ CD8 T Cells

Total visits

views
AXL Targeting Restores PD-1 Blockade Sensitivity of STK11/LKB1 Mutant NSCLC Through Expansion of TCF1+ CD8 T Cells 2

Total visits per month

views
October 2023 0
November 2023 0
December 2023 0
January 2024 0
February 2024 0
March 2024 2
April 2024 0

File Visits

views
LI-PRIMARY-2022-1.pdf 14

Top country views

views
United States 2